Farletuzumab ecteribulin

Farletuzumab ecteribulin
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T77908-5mg 5 mg

5 - 10 business days*

3,289.00€
 
Description: Farletuzumab ecteribulin (MORAb-202) is a highly cytotoxic antibody-drug conjugate... more
Product information "Farletuzumab ecteribulin"
Description: Farletuzumab ecteribulin (MORAb-202) is a highly cytotoxic antibody-drug conjugate (ADC) targeting human folate receptor alpha (FRA). This ADC comprises the humanized Farletuzumab antibody linked to Mal-PEG2-Val-Cit-PAB-eribulin through reduced interchain disulfide bonds, with an agent-to-antibody ratio of 4.0, demonstrating potent antitumor activity against FRA-positive cells in vitro. Target: Others, Antibody-Drug Conjugates (ADCs)
Keywords: MORAb-202
Supplier: TargetMol
Supplier-Nr: T77908

Properties

Application: Targets folate receptor (FOLR)
Conjugate: No

Database Information

CAS : 2407465-18-1| Matching products
KEGG ID : K07375 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Farletuzumab ecteribulin"
Write a review
or to review a product.
Viewed